ID

34476

Descripción

Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01368055

Link

https://clinicaltrials.gov/show/NCT01368055

Palabras clave

  1. 17/1/19 17/1/19 -
  2. 27/5/19 27/5/19 -
  3. 15/3/21 15/3/21 - Dr. rer. medic Philipp Neuhaus
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

17 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT01368055

Eligibility Prostate Cancer NCT01368055

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
prostate cancer.
Descripción

ID.1

Tipo de datos

boolean

gleason score 2-6 or 7.
Descripción

ID.2

Tipo de datos

boolean

psa ≤ 20 ng/ml.
Descripción

ID.3

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous prostate cancer surgery or pelvic radiation.
Descripción

ID.4

Tipo de datos

boolean

prior/concurrent systemic chemotherapy for prostate cancer.
Descripción

ID.5

Tipo de datos

boolean

active inflammatory bowel disease (crohn's disease, diverticulitis or ulcerative colitis) affecting the rectum.
Descripción

ID.6

Tipo de datos

boolean

history of hip replacement.
Descripción

ID.7

Tipo de datos

boolean

prior intrapelvic surgery.
Descripción

ID.8

Tipo de datos

boolean

taking saw palmetto or methotrexate and unable or unwilling to discontinue its uses during radiation.
Descripción

ID.9

Tipo de datos

boolean

receiving continuous and current anticoagulation with warfarin sodium (coumadin), clopidogrel bisulfate (plavix), dabigatran etexilate mesylate (pradaxa),enoxaparin sodium (lovenox), or aspirin/er dipyridamole (aggrenox).
Descripción

ID.10

Tipo de datos

boolean

Similar models

Eligibility Prostate Cancer NCT01368055

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
prostate cancer.
boolean
ID.2
Item
gleason score 2-6 or 7.
boolean
ID.3
Item
psa ≤ 20 ng/ml.
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
previous prostate cancer surgery or pelvic radiation.
boolean
ID.5
Item
prior/concurrent systemic chemotherapy for prostate cancer.
boolean
ID.6
Item
active inflammatory bowel disease (crohn's disease, diverticulitis or ulcerative colitis) affecting the rectum.
boolean
ID.7
Item
history of hip replacement.
boolean
ID.8
Item
prior intrapelvic surgery.
boolean
ID.9
Item
taking saw palmetto or methotrexate and unable or unwilling to discontinue its uses during radiation.
boolean
ID.10
Item
receiving continuous and current anticoagulation with warfarin sodium (coumadin), clopidogrel bisulfate (plavix), dabigatran etexilate mesylate (pradaxa),enoxaparin sodium (lovenox), or aspirin/er dipyridamole (aggrenox).
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial